NasdaqGS:ENSGHealthcare
Ensign Group (ENSG): Revisiting Valuation After Strong Q3 Revenue Beat and Upgraded EPS Guidance
Ensign Group (ENSG) just turned in a Q3 that caught Wall Street’s eye, with revenue up about 20% year over year and both sales and full year EPS guidance topping expectations.
See our latest analysis for Ensign Group.
The solid Q3 update is landing against a backdrop of strong momentum, with a roughly 32 percent year to date share price return and a standout 142 percent five year total shareholder return suggesting investors are steadily rewarding Ensign’s growth profile.
If this kind of...